Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 ...

The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...

Este artículo estará disponible en español en El Tiempo Latino. An abundance of evidence indicates the mRNA COVID-19 vaccines ...

Results from a randomized control trial published Nov. 6 in JAMA Network Open show that participants who received mRNA ...

Southwest District Health ended its COVID-19 vaccination program. Others in Texas, Florida and Michigan also pushed back against the vaccine.

In October, the Centers for Disease Control and Prevention recommended that high-risk adults get a second updated Covid ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

The optimal time to get your seasonal flu shot, according to the Food and Drug Administration (FDA), is right now: flu ...

The Supreme Court hasn’t released any opinions during its current term, and none of its decisions since the pandemic match ...

Dr. Ashish Jha, dean of the Brown University School of Public Health and the former White House Covid-19 response coordinator ...

Working with animals, Penn researchers modified the mRNA vaccine to target C. difficile, an infection that kills 30,000 in ...

The authors said the main outcomes of the study were reactogenicity, including fever, chills, muscle aches, and/or joint pain ...